Chicago, IL, United States of America

Dapeng Zhou

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Brigham Young University, Scripps Research Institute, The University of Chicago. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dapeng Zhou. Retrieved from https://idiyas.com/inventor/dapeng-zhou-7w5ke1j0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dapeng Zhou: Innovator in NKT Cell Activation

Introduction

Dapeng Zhou is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of immunology, particularly in the activation of NKT cells. His innovative methods have the potential to advance therapeutic strategies in various medical applications.

Latest Patents

Dapeng Zhou holds a patent titled "Methods of activating NKT cells." This patent describes methods that involve contacting NKT cells with isoglobotrihexosylceramide (iGb3) to induce cytokine secretion, stimulate cell proliferation, or upregulate cell surface markers. This groundbreaking work opens new avenues for activating NKT cell populations in subjects.

Career Highlights

Throughout his career, Dapeng Zhou has worked with prestigious institutions such as Brigham Young University and The Scripps Research Institute. His research has focused on enhancing the understanding of NKT cell functions and their applications in immunotherapy.

Collaborations

Dapeng Zhou has collaborated with esteemed colleagues, including Paul B. Savage and Albert Bendelac. These partnerships have contributed to the advancement of research in the field of immunology.

Conclusion

Dapeng Zhou's innovative work in NKT cell activation showcases his commitment to advancing medical science. His contributions are poised to have a lasting impact on immunotherapy and related fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…